These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843 [TBL] [Abstract][Full Text] [Related]
5. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Thomas DA; Faderl S; O'Brien S; Bueso-Ramos C; Cortes J; Garcia-Manero G; Giles FJ; Verstovsek S; Wierda WG; Pierce SA; Shan J; Brandt M; Hagemeister FB; Keating MJ; Cabanillas F; Kantarjian H Cancer; 2006 Apr; 106(7):1569-80. PubMed ID: 16502413 [TBL] [Abstract][Full Text] [Related]
6. Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy. Alwan F; He A; Montoto S; Kassam S; Mee M; Burns F; Edwards S; Wilson A; Tenant-Flowers M; Marcus R; Ardeshna KM; Bower M; Cwynarski K AIDS; 2015 May; 29(8):903-10. PubMed ID: 25730506 [TBL] [Abstract][Full Text] [Related]
7. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients. Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525 [TBL] [Abstract][Full Text] [Related]
9. Short communication: spectrum of non-Hodgkin lymphoma in an urban Ryan White-funded clinic in the established antiretroviral era. Silverton A; Gunthel C; Adamski M; Mosunjac M; Nguyen ML AIDS Res Hum Retroviruses; 2014 Jul; 30(7):665-9. PubMed ID: 24707838 [TBL] [Abstract][Full Text] [Related]
10. Adult Burkitt lymphoma: advances in diagnosis and treatment. Aldoss IT; Weisenburger DD; Fu K; Chan WC; Vose JM; Bierman PJ; Bociek RG; Armitage JO Oncology (Williston Park); 2008 Nov; 22(13):1508-17. PubMed ID: 19133605 [TBL] [Abstract][Full Text] [Related]
11. Prospective study of Burkitt lymphoma treatment in adolescents and adults in Malawi. Painschab MS; Westmoreland KD; Kasonkanji E; Zuze T; Kaimila B; Waswa P; El-Mallawany NK; Tomoka T; Mulenga M; Montgomery ND; Fedoriw Y; Gopal S Blood Adv; 2019 Feb; 3(4):612-620. PubMed ID: 30796065 [TBL] [Abstract][Full Text] [Related]
12. [Successful treatment with hyper-CVAD and highly active anti-retroviral therapy (HAART) for AIDS-related Burkitt lymphoma]. Suzuki K; Nakazato T; Sanada Y; Mihara A; Tachikawa N; Kurai H; Yoshimura Y; Hayashi H; Yoshida S; Kakimoto T Rinsho Ketsueki; 2010 Mar; 51(3):207-12. PubMed ID: 20379116 [TBL] [Abstract][Full Text] [Related]
14. Rituximab in combination with chemotherapy versus chemotherapy alone in HIV-associated non-Hodgkin lymphoma: a pooled analysis of 15 prospective studies. Castillo JJ; Echenique IA Am J Hematol; 2012 Mar; 87(3):330-3. PubMed ID: 22308010 [TBL] [Abstract][Full Text] [Related]
15. AIDS-associated Burkitt or Burkitt-like lymphoma: short intensive polychemotherapy is feasible and effective. Hoffmann C; Wolf E; Wyen C; Fätkenheuer G; Van Lunzen J; Stellbrink HJ; Stoehr A; Plettenberg A; Jaeger H; Noppeney R; Hentrich M; Goekbuget N; Hoelzer D; Horst HA Leuk Lymphoma; 2006 Sep; 47(9):1872-80. PubMed ID: 17065000 [TBL] [Abstract][Full Text] [Related]
16. Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma. Montoto S; Wilson J; Shaw K; Heath M; Wilson A; McNamara C; Orkin C; Nelson M; Johnson M; Bower M; Cwynarski K AIDS; 2010 Mar; 24(6):851-6. PubMed ID: 20124971 [TBL] [Abstract][Full Text] [Related]
17. High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients. Oriol A; Ribera JM; Bergua J; Giménez Mesa E; Grande C; Esteve J; Brunet S; Moreno MJ; Escoda L; Hernandez-Rivas JM; Hoelzer D Cancer; 2008 Jul; 113(1):117-25. PubMed ID: 18457327 [TBL] [Abstract][Full Text] [Related]
18. Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG). Hentrich M; Hoffmann C; Mosthaf F; Müller M; Siehl J; Wyen C; Hensel M; ; Ann Hematol; 2014 Jun; 93(6):913-21. PubMed ID: 24807241 [TBL] [Abstract][Full Text] [Related]
19. [Recent advances and the treatment strategies of AIDS-related malignant lymphoma]. Okada S Rinsho Ketsueki; 2008 Oct; 49(10):1490-8. PubMed ID: 18833933 [No Abstract] [Full Text] [Related]
20. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Pfreundschuh M; Trümper L; Osterborg A; Pettengell R; Trneny M; Imrie K; Ma D; Gill D; Walewski J; Zinzani PL; Stahel R; Kvaloy S; Shpilberg O; Jaeger U; Hansen M; Lehtinen T; López-Guillermo A; Corrado C; Scheliga A; Milpied N; Mendila M; Rashford M; Kuhnt E; Loeffler M; Lancet Oncol; 2006 May; 7(5):379-91. PubMed ID: 16648042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]